Page 1603 - Small Animal Internal Medicine, 6th Edition
P. 1603

Index  1575


            Sympathomimetic drugs (Continued)  Tamsulosin, 733t–734t  Thoracic radiography (Continued)  Thromboembolism (Continued)
             dosage of, 90t–91t       Tapeworms, 487–488          pleural effusion, 360     in dogs
             feline bronchitis treated with, 332  Target organs, 211  radiographs of, 288–295  clinical features of, 230–231
  VetBooks.ir  cardiovascular causes of, 3  Telogen defluxion, 748t  vascular patterns of, 288–290, 289f,   diagnosis of, 231
                                                                                             coagulation tests for, 231
            Syncope
                                                                  torsion of, 294–295
                                      Taurine, 151, 170–171
                                      Temporal muscle atrophy, 1223f
             causes of, 2b
                                                                     289b
                                                                                             diseases associated with, 230–233
             heart failure and, 1–3
                                      Tension pneumothorax, 376
                                                                 peritoneopericardial diaphragmatic
             test for, 2–3            Tenesmus, 403–404, 403b, 1001  Paragonimus kellicotti of, 345  echocardiographic findings, 231
                                                                                             physical examination findings,
            Synovial fluid            Terbinafine, 386t–388t, 472, 1504t  hernia, 174–175       231
             collection and analysis of   Terbutaline sulfate, 386t–388t,   pulmonary hypertension with shunt   prognosis for, 231–232
                arthrocentesis for, 1189,   1034t–1036t             reversal, 115            prophylaxis against, 232–233
                1190f–1191f            in cats, 90t–91t, 327b    pyothorax, 371              radiographic findings, 231
               collection methods, 1190, 1190f  description of, 98  trachea, 287–288         thromboelastography for, 231
               gross appearance, 1190–1192, 1192f  in dogs, 90t–91t, 327b  vascular ring anomalies on, 116  treatment of, 231–232
               smear preparation, 1190, 1192f  dosage of, 90t–91t  ventrodorsal view of, 287  warfarin for, 232–233
             culture of, 1193          uterine contractility suppression using,   views of, 287  prophylaxis against, 230, 232–233
             description of, 1188–1189, 1189t  962             Thoracocentesis, 366–367    caudal aortic, 1162–1163
            Synovial membrane biopsy, 1193  Testes, canine, 996–997, 996f  catheters for, 367  coronary artery, 231
            Syringomyelia, 1155, 1155f  Testicular neoplasia, 996–997, 996f–997f  chylothorax treated with, 374  diagnosis of, 1405
            Systemic arterial hypertension, 211–220  Testicular parenchyma, 1001f  congestive heart failure treated with,   diseases associated with, 223b
            Systemic inflammatory response   Testicular torsion, 991, 991f  129            endothelial damage, 221
               syndrome (SIRS), 432, 475  Tetanus, 1181–1182, 1182f  description of, 61    general considerations for, 221–224
            Systemic lupus erythematosus  Tetany                 indications for, 366      in glomerular disease, 684–685
             antinuclear antibody test for, 1194,   hypocalcemic, 928  pleural effusion treated with, 167, 360,   hypercoagulability secondary to, 223
                1205, 1217, 1248       puerperal, 975               366                    in immune-mediated hemolytic
             clinical features of, 1247  Tetracyclines, 386t–388t, 1437t–1439t  pneumothorax treated with, 345  anemia, 1237
             diagnosis of, 1194, 1247–1248  Tetralogy of Fallot  spontaneous pneumothorax treated   pathophysiology of, 222–224
             etiology of, 1247         clinical features of, 114    with, 377              prevention of, 1237
             lupus erythematosus test for, 1194,   cyanosis caused by, 113–114  technique for, 367  pulmonary
                1217, 1247             diagnosis of, 114       Thoracolumbar disk extrusion, 1138t,   abnormalities associated with, 355b
             polyarthritis caused by, 1204–1205  dog breeds affected by, 102t  1139–1141, 1140f, 1140t  clinical features of, 355
             signs of, 1248t           etiology of, 113–114    Thoracoscopy, 312            computed tomography pulmonary
             treatment of, 1248–1249   pathophysiology of, 113–114  with lung biopsy, 312      angiography of, 356
            Systemic vasculitis, 1453  prognosis for, 114      Thoracotomy, 367             D-dimer measurements, 355
            Systole, 8                 treatment of, 114         exploratory, 373–374       description of, 194, 224, 354–356
            Systolic anterior motion (SAM), 26  Tetraparesis, 1045t  Thorazine. see Chlorpromazine  diagnosis of, 355–356
            Systolic clicks, 9        Tetraplegia, 1045t       Three-dimensional echocardiography, 33  fibrinolytic agents for, 356
            Systolic murmurs          Theophylline, 386t–388t  Thrombin, 221–222            heartworm disease as cause of,
             in cats, 159              canine chronic bronchitis treated with,   Thrombocytopenia  201–203, 224
             description of, 9–11         327, 327b              approach to, 1395–1396     pleural effusion caused by, 360
            Systolic time intervals (STIs), 27  feline bronchitis treated with, 332  causes of, 1393, 1395b  postadulticide, 201–203
                                       idiopathic pulmonary fibrosis treated   description of, 1278, 1345t  prevention of, 356
            T                             with, 351              diagnostic tests for, 1218t–1219t  prognosis for, 356
            T3. see Triiodothyronine  Theriogenology, 935–952    drug-associated, 1395      selective angiography of, 356
            T4. see Thyroxine          definition of, 935        fever associated with, 1426t  treatment of, 356
            Tachyarrhythmias           estrous cycle, 937–940, 938t. see also   immune-mediated  sequelae of, 221
             atrial fibrillation. see Atrial fibrillation  Estrous cycle; Estrus  causes of, 1241t  in spontaneous hyperadrenocorticism,
             rapid irregular rhythms, 79  prebreeding consultation, 935–937  classification of, 1240  224
             rapid regular rhythms, 79–80  Thiabendazole, 515t–517t  clinical features of, 1240, 1242f  Thrombolysis, 222
             sinus tachycardia, 79–80  Thiacetarsamide, 200       description of, 1396–1397  Thrombolytic therapy, 227b
             supraventricular         Thiamine deficiency, 1078, 1115  diagnosis of, 1240–1244, 1248t  Thrombosis, 1405, 1405f
               acute therapy for, 80–82  Thiazide diuretics, 67   etiology of, 1240        portal vein, 233
               algorithm for, 81f     Thiobarbiturates, 49b       feline, 1244             vena caval, 233
               mechanisms of, 78      Thiopurine methyltransferase, 1223  immunosuppressive drugs for, 1243  venous, 233–234
               oral therapy for, 80   Third-degree atrioventricular block,   physical examination of, 1240, 1242f  Thymomas, 1172
               refractory, 80           43–44, 44f                prognosis for, 1244    Thyroglobulin, 776b, 779
               vagal maneuver for, 82  Third eyelid protrusion, 1091, 1091f  supportive care for, 1243–1244  Thyroglobulin autoantibodies, 777,
             supraventricular tachycardia, 80–82  Third heart sound, 9  treatment of, 1243  956
             ventricular              Thoracic auscultation, 7, 285–286  in lymphadenopathy, 1415  Thyroid adenomas, 800
               acute therapy for, 82–84  Thoracic limb withdrawal reflex, 1049,   spontaneous bleeding caused by, 1387  Thyroid carcinomas, 800
               algorithm for, 83f       1050f                  Thrombocytosis, 1426t     Thyroid gland
               in Boxers, 148         Thoracic radiography. see also   Thromboelastography, 224, 231, 355,   disorders of, 767–805
               chronic oral therapy for, 84  Radiography          1361, 1405f              function tests, 774–779
               description of, 82      arrhythmogenic right ventricular   Thromboembolic disease, 221–239  antibody tests for lymphocytic
               refractory, 83–84          cardiomyopathy, 171  Thromboembolism                 thyroiditis, 779
               treatment of, 83f       arterial thromboembolism evaluations,   arterial     baseline serum fT 4 concentration,
            Tachycardia, 37               225                     in cats, 224–230             776–777
             atrial                    bacterial pneumonia findings, 343  anticoagulant therapy, 227b  baseline serum thyroid-stimulating
               causes of, 39           caval syndrome, 202          antiplatelet therapy, 227b, 228  hormone concentration,
               management of, 82       chest tube placement verification   azotemia associated with,   777–778, 778f
               sustained, 42f             using, 369                  225–226               baseline serum triiodothyronine
             atrioventricular reciprocating, 44–45  degenerative atrioventricular valve   cardiomyopathy as cause of, 224,   concentrations, 775–776, 776b
             paroxysmal AV reciprocating, 80–82  disease, 122, 123f   224f                  breed variations, 781–782
             ventricular               dorsoventral views of, 287   causes of, 1405         drugs that affect, 780–781, 781t
               acute therapy for, 82–84  feline bronchitis, 330     clinical features of, 224–225, 225f,   factors that affect, 779–782
               chronic oral therapy for, 84  general principles of, 287  226b               overview of, 774–775, 775f–776f
               electrocardiography of, 41  lower respiratory tract disorders, 286  diagnosis of, 225–226  thyroid stimulating hormone and
               intermittent paroxysms of, 42f  lungs                echocardiographic findings, 225  thyrotropin-releasing hormone
               lidocaine for, 82        alveolar pattern, 290–292, 291f, 291b  heparin for, 227b, 228  stimulation tests, 778–779
               polymorphic, 41          atelectasis, 294, 294f      limb function after treatment for,   variables that affect, 777t
               treatment of, 82–84      bronchial pattern, 290, 290f, 290b,   229–230      idiopathic atrophy of, 767
            Tachycardia-induced cardiomyopathy,   293f              prognosis for, 226–230  Thyroid hormones
               152                      cavitary lesions, 294, 295f  prophylaxis against, 230  autoantibodies, 769t, 776b
            Tachypnea, 4                interstitial pattern, 292–293, 292f  radiographic findings, 225  Greyhound levels of, 1363
            Tachyzoites, 1520           lobes consolidation of, 293–294,   thrombolytic therapy for, 227b  secretion of, 774–775
            Tagamet. see Cimetidine        294f                     treatment of, 226–230, 227b  Thyroid mass, 802f
   1598   1599   1600   1601   1602   1603   1604   1605   1606